Activin A and Follistatin-Like 3 Determine the Susceptibility of Heart to Ischemic Injury
暂无分享,去创建一个
K. Tsuchida | E. Lara-Pezzi | K. Walsh | D. Pimentel | N. Ouchi | Kyriakos N. Papanicolaou | Se-Jin Lee | M. Shimano | K. Panse | Yuichi Oshima
[1] K. Walsh,et al. Follistatin-like 1, a Secreted Muscle Protein, Promotes Endothelial Cell Function and Revascularization in Ischemic Tissue through a Nitric-oxide Synthase-dependent Mechanism* , 2008, Journal of Biological Chemistry.
[2] N. Rosenthal,et al. Expression of follistatin-related genes is altered in heart failure. , 2008, Endocrinology.
[3] K. Walsh,et al. Follistatin-Like 1 Is an Akt-Regulated Cardioprotective Factor That Is Secreted by the Heart , 2008, Circulation.
[4] J. Schneider,et al. Angiogenic-regulatory network revealed by molecular profiling heart tissue following Akt1 induction in endothelial cells , 2008, Angiogenesis.
[5] T. Amit,et al. The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases , 2007, Journal of neurochemistry.
[6] W. D. Fairlie,et al. Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1 , 2007, Nature Medicine.
[7] S. Engelhardt,et al. A Secretion Trap Screen in Yeast Identifies Protease Inhibitor 16 as a Novel Antihypertrophic Protein Secreted From the Heart , 2007, Circulation.
[8] M. Hedger,et al. Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia , 2007, Proceedings of the National Academy of Sciences.
[9] P. Ponikowski,et al. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. , 2007, Journal of the American College of Cardiology.
[10] S. Kihara,et al. Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment. , 2007, Cardiovascular research.
[11] R. Califf,et al. Prognostic Value of Growth-Differentiation Factor-15 in Patients With Non–ST-Elevation Acute Coronary Syndrome , 2007, Circulation.
[12] T. O’Connell,et al. Isolation and culture of adult mouse cardiac myocytes. , 2007, Methods in molecular biology.
[13] E. Rosen,et al. FSTL3 deletion reveals roles for TGF-β family ligands in glucose and fat homeostasis in adults , 2007, Proceedings of the National Academy of Sciences.
[14] I. Shiojima,et al. Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure. , 2006, Physiological genomics.
[15] S. Cook,et al. Myostatin Regulates Cardiomyocyte Growth Through Modulation of Akt Signaling , 2006, Circulation research.
[16] I. Shiojima,et al. Vascular Endothelial Growth Factor Blockade Promotes the Transition From Compensatory Cardiac Hypertrophy to Failure in Response to Pressure Overload , 2006, Hypertension.
[17] H. Drexler,et al. The Transforming Growth Factor-&bgr; Superfamily Member Growth-Differentiation Factor-15 Protects the Heart From Ischemia/Reperfusion Injury , 2006 .
[18] T. Hewett,et al. GDF15/MIC-1 Functions As a Protective and Antihypertrophic Factor Released From the Myocardium in Association With SMAD Protein Activation , 2006, Circulation research.
[19] H. Drexler,et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. , 2006, Circulation research.
[20] D. Phillips,et al. Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[21] S. Kihara,et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2–dependent mechanisms , 2005, Nature Medicine.
[22] I. Shiojima,et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. , 2005, The Journal of clinical investigation.
[23] I. Kawase,et al. Smad1 Protects Cardiomyocytes From Ischemia-Reperfusion Injury , 2005, Circulation.
[24] G. Takemura,et al. Postinfarction Gene Therapy Against Transforming Growth Factor-β Signal Modulates Infarct Tissue Dynamics and Attenuates Left Ventricular Remodeling and Heart Failure , 2005 .
[25] G. Takemura,et al. Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure. , 2004, Circulation.
[26] S. Kihara,et al. Adiponectin-mediated modulation of hypertrophic signals in the heart , 2004, Nature Medicine.
[27] Michael D. Schneider,et al. Transgenic Expression of Bcl-2 Modulates Energy Metabolism, Prevents Cytosolic Acidification During Ischemia, and Reduces Ischemia/Reperfusion Injury , 2004, Circulation research.
[28] G. Christensen,et al. Elevated Levels of Activin A in Heart Failure: Potential Role in Myocardial Remodeling , 2004, Circulation.
[29] G. Taffet,et al. Bcl-2 overexpression corrects mitochondrial defects and ameliorates inherited desmin null cardiomyopathy. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[30] R. Voutilainen,et al. Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis. , 2003, The Journal of endocrinology.
[31] J. Massagué,et al. Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.
[32] J. Massagué,et al. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. , 2003, Cell.
[33] F. Netter,et al. Supplemental References , 2002, We Came Naked and Barefoot.
[34] G. Krystal,et al. Activin/TGF-β induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP , 2002, Nature Cell Biology.
[35] T. Zimmers,et al. Induction of Cachexia in Mice by Systemically Administered Myostatin , 2002, Science.
[36] T. Doetschman,et al. TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II , 2002 .
[37] T. Doetschman,et al. TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. , 2002, The Journal of clinical investigation.
[38] S. Werner,et al. Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis , 2001, The EMBO journal.
[39] Y. Fujio,et al. Bone Morphogenetic Protein-2 Inhibits Serum Deprivation-induced Apoptosis of Neonatal Cardiac Myocytes through Activation of the Smad1 Pathway* , 2001, The Journal of Biological Chemistry.
[40] R. Kitsis,et al. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. , 2000, Circulation.
[41] R. Balling,et al. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair , 1999, The EMBO journal.
[42] P. Gluckman,et al. Administration of recombinant human activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease , 1999, Neuroscience.
[43] P. Gluckman,et al. Expression of the activin axis and neuronal rescue effects of recombinant activin A following hypoxic-ischemic brain injury in the infant rat 1 Published on the World Wide Web on 8 June 1999. 1 , 1999, Brain Research.
[44] K. Matthews,et al. Myostatin, a transforming growth factor‐β superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct , 1999, Journal of cellular physiology.
[45] R. Jaenisch,et al. Functional analysis of activins during mammalian development , 1995, Nature.
[46] A. Bradley,et al. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[47] W. Fischer,et al. Activin is a nerve cell survival molecule , 1990, Nature.
[48] H. Shibai,et al. Erythroid differentiation factor is encoded by the same mRNA as that of the inhibin beta A chain. , 1988, Proceedings of the National Academy of Sciences of the United States of America.